The CIS insulin market size is expected to reach USD 4.67 billion by 2030, registering a CAGR of 5.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The presence of an extensive pipeline portfolio of products exhibiting higher efficacies and their su...

The Asia Pacific insulin market size is expected to reach USD 7.09 billion by 2030, expanding at a CAGR of 5.3% from 2024 to 2030, according to a new study by Grand View Research, Inc. Growing regional prevalence of diabetes, increasing market penetration rates of modern insul...